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Abstract
Background: Pregnant women are a target group for receipt of influenza vaccine because there appears to be an elevated
mortality and morbidity rate associated with influenza virus infection in pregnant women. The goal of this study is to
determine the factors affecting the decisions of pregnant women in Turkey to be vaccinated or not for 2009 H1N1 influenza.
Methodology: We enrolled 314 of 522 (60.2%) pregnant women who attended to the antenatal clinics of the Medical
Faculty of Kahramanmaras Sutcuimam University’s Department of Gynecology and Obstetrics between December 23, 2009,
and February 1, 2010. We developed a 48-question survey which was completed in a face-to-face interview at the clinic with
each pregnant woman.
Principal Findings: Of the 314 pregnant women, 27.4% were in the first trimester, 33.8% were in the second trimester, and
38.8% were in the third trimester. Twenty-eight pregnant women (8.9%) got vaccinated. Of all the women interviewed,
68.5% stated that they were comfortable with their decisions about the vaccine, 7.3% stated they were not comfortable,
and 24.2% stated that they were hesitant about their decisions. The probability of receiving the 2009 H1N1 vaccine was 3.46
times higher among working women than housewives, 1.85 times higher among women who have a child than those who
do not, and 1.29 times higher among women with a high-school education or higher than those with only a secondary-
school education and below. Correct knowledge about the minimal risks associated with receipt of influenza vaccine were
associated with a significant increase in the probability of receiving the 2009 H1N1 vaccine.
Conclusions/Significance: The number of pregnant women in the study group who received the 2009 H1N1 vaccine was
very low (8.9%) and two-thirds of them stated that they were comfortable with their decisions concerning the vaccine. Our
results may have implications for public health measures to increase the currently low vaccination rate among pregnant
women. Further studies are required to confirm whether our findings generalize to other influenza seasons and other
settings.
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Introduction
2009 H1N1 has been identified as the cause of a widespread
outbreak of febrile respiratory infection worldwide [1]. In both
seasonal influenza epidemics [2,3] and previous pandemics
[4,5,6], the mortality and morbidity rate from influenza infection
was higher in pregnant women than in non-pregnant women.
Mechanical, immunologic, and hormonal changes in pregnancy
contribute to this increased risk [3,7,8]. More pregnant women
than non-pregnant women are hospitalized due to acute
respiratory diseases and cardiopulmonary cases [2,3,9]. The
influenza vaccination is the most effective way to protect pregnant
women from influenza [10]. The World Health Organization
Strategic Advisory Group of Experts, the European Union Health
Security Committee and the Early Warning and Response system,
and the United States Advisory Committee on Immunization
Practices, have all stated that pregnant women should receive
precedence in receiving the 2009 H1N1 vaccine [11,12,13,14].
In Turkey, pandemic flu cases have been seen in every city by
November 15, 2009. Laboratory examination has determined that
627 people have died due to pandemic flu. Of these, 40 were
pregnant or puerperant. On November 2, 2009 the Turkish
Ministry of Health announced that all health workers were to
receive vaccinations. On November 16, 2009 this vaccination
group was expanded to include children under 5 years of age. On
December 7, 2009 the Ministry of Health announced that
pregnant women could receive vaccinations. And finally, on
December 17, 2009 the entire Turkish population could be
vaccinated. At this point, the Ministry of Health conducted a free
mass vaccination campaign [15]. This push sparked the Turkish
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debating the safety and efficacy of the 2009 H1N1 vaccine.
This study aims to determine the factors affecting the 2009
H1N1 vaccination situation, and the decisions of pregnant women,
a pandemic risk group, whether to be vaccinated or not.
Methods
This study was conducted at the antenatal clinics of the Medical
Faculty of Kahramanmaras Sutcuimam University’s Department
of Gynecology and Obstetrics (Kahramanmaras, Turkey) between
December 23, 2009 and February 1, 2010. During that time 522
pregnant women applied to our antenatal clinic, 314 (60.2%) of
whom choose to join the study. The remaining 208 (39.8%)
refused to be involved in the study. We obtained research ethics
approval from the Ethics Committee of Kahramanmaras
Sutcuimam University before initiating the study, and collected
signed informed consent from all subjects.
We drew information from the literature to develop a 48-
question survey. One of our researchers then used this survey to
conduct face-to-face interviews at the clinic with each pregnant
woman. Ten questions were related to sociodemographic
characteristics, 1 to status of the vaccination, 1 to the person
who made the decision whether or not to vaccinate, 1 to whether
the participant felt comfortable or not with her decision about the
vaccination, 10 to the factors affecting the participant deciding
whether or not to vaccinate, 15 to ‘‘2009 H1N1 vaccine’s side
effects (HVSE),’’ three to ‘‘2009 H1N1 vaccine’s side effects
related to pregnancy (HVSERP),’’ and four to ‘‘beliefs about a
mass 2009 H1N1 vaccination campaign conspiracy (BMHVCC).’’
Three questions related to ‘‘other attitudes and beliefs related to
2009 H1N1 vaccine (ABRHV).’’ Each correct answer for
questions related to HVSE, HVSERP, BMHVCC, and ABRHV
was calculated as one point and the total points in each sub-group
were calculated.
Statistical Analysis
We used the Statistical Package for Social Sciences (SPSS Inc.,
Chicago, IL,USA), version 15.0, to perform statistical analyses.The
data were initially tested for normal distribution via the Kolmo-
gorov-Smirnov test and foundto be abnormal (p,0.05).We utilized
chi-square and Mann-Whitney U tests to compare among groups.
Logistic regression was used to determine the independent effects of
the associations between vaccination decision and explanatory
variables, estimating the adjusted odds ratio and confidence
intervals (95%). A multivariable logistic regression model included
variables whose associations with vaccination decisions were
statistically significant, defined as p,0.05.
Results
The average age of the pregnant women in the study was
26.565.2 years. Of the total, 27.4% of the women were in the first
trimester, 33.8% were in the second trimester, and 38.8% were in
the third trimester of pregnancy. Of the 314 pregnant women,
8.9% (28 women) decided to get the vaccine. Based on age groups,
education, place of residence, chronic disease situation, and
trimester at the time of the survey, there was not any significant
difference with regard to vaccination status (p.0.05). However,
regarding occupation, housewives received statistically significantly
fewer 2009 H1N1 vaccinations than did women of working group
(p,0.05) (Table 1).
With respect to spouses, 37.9% of the study group stated that
they made their decisions on their own, 10.5% said their
vaccination decisions were made by their spouses, and 51.5% said
they decided with their spouses. In addition, 68.5% of the
pregnant women stated that they were comfortable with the
decisions they made concerning the vaccine, 7.3% stated that
they were not comfortable, and 24.2% stated that they were
hesitant. The decisions of having vaccination were affected by
television, health personnel, and suggestions from relatives. The
decisions of not vaccinating were affected by television,
explanations from the Ministry of Health, and explanations from
politicians.
The median HVSE points of the pregnant women who were
and were not vaccinated were three and the differences among the
groups was statistically insignificant (p.0.05). The median
BMHVCC points of the pregnant women who were and were
not vaccinated were 1 and the differences among the groups was
statistically insignificant (p.0.05). Although the median HVSERP
points of pregnant women who were vaccinated were 0.5, the
median HVSERP points of pregnant women who were not
vaccinated were 0, and this difference was statistically significant
(p,0.05) (Table 2).
Table 1. The affect of sociodemographic characteristics on
the 2009 H1N1 vaccination status of pregnant women.
Vaccination status
Vaccinated
n=28
Not
Vaccinated
n=286
Variables % % P*
Age
24 and below 7.4 92.6
25–29 6.5 93.5 0.14
30 and above 14.1 85.9
Education
Secondary school and below 7.3 92.7 0.09
High school and above 13.4 86.6
Occupation
Housewife 6.3 93.7 ,0.001
Working 20.3 79.7
Place of Residence
City centre 7.9 92.1
District centre 7.9 92.1 0.56
Other 11.8 88.2
Number of Children
0 7.9 92.1
1 4.9 95.1 0.04
2 16.3 83.7
3 and above 5.2 94.8
Chronic Disease
Yes 8.4 91.6 0.43
No 11.8 88.2
Trimester
1 9.3 90.7
2 11.3 88.7 0.44
3 6.6 93.4
*; Chi-square test.
doi:10.1371/journal.pone.0014177.t001
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we calculated the odds ratios of the factors we thought could have
contributed to the vaccination decision. The vaccination rate was
higher among the pregnant women who were working and who
answered correctly the questions related to the HVSERP
(Table 3).
In the research group, 62.4% of the participants thought that
the 2009 H1N1 vaccine would only be tested in Turkey, 77.4%
stated that there are some other countries manipulating the
receipt of the 2009 H1N1 vaccine, and 75.5% thought that the
vaccine was harmful in the long term. Moreover, 70.1% of the
pregnant women believed that the vaccine could cause a
miscarriage, 74.2% thought it could cause deformation in their
children, and 72.3% were worried that the vaccine could cause
infertility (Table S1).
Discussion
Media broadcasts and discussion programs have brought about
social anxiety and hesitation about the safety of the 2009 H1N1
vaccine in Turkey and many other countries [16]. This situation
has affected the vaccination rate of pregnant women, as well as all
of society [17]. The 2009 H1N1 vaccine is a new vaccination and
the entire world is curious about its effectiveness and reliability
[18]. Since the vaccine can show adverse effects on a fetus, many
pregnant women are unwilling to adopt the recommendations of
public health authorities [19].
Many around the world hold different opinions about the
vaccine. It was found that 2% of pregnant women [20] in a 2000
Canadian study and 12.8% of pregnant women [21] in an
American study had received the seasonal influenza vaccine. In
Table 2. The univariate analysis of factors affecting the vaccination status of pregnant women.
Vaccination status
Vaccinated
n=28
Not Vaccinated
n=286
Variables n % n % p
The vaccine protects 100% against the 2009 H1N1
Yes 20 9.5 190 90.5 0.59*
No 8 7.7 96 92.3
The 2009 H1N1 spreads much faster than the seasonal flu
Yes 4 6.1 62 93.9 0.36*
No 24 9.7 224 90.3
The fatality of 2009 H1N1 is lower than that of the seasonal flu
Yes 24 9.6 227 90.4 0.42*
No 4 6.3 59 93.7
HVSE (Min.-Med.-Max)
0-3-12
(Min.-Med.-Max)
0-3-12
0.66**
HVSERP (Min.-Med.-Max)
0-0.5-3
(Min.-Med.-Max)
0-0-3
0.02**
BMHVCC (Min.-Med.-Max)
0-1-4
(Min.-Med.-Max)
0-1-4
0.34**
*; Chi-square test.
**; Mann-Whitney U test.
doi:10.1371/journal.pone.0014177.t002
Table 3. Multiple logistic regression analysis of the independent variables affecting the decision of vaccination of pregnant
women.
Factors Odds Ratio % 95 Confidence Interval p value
HVSERP 1.34 1.00–1.79 0.04
Education
Secondary school and below 1.00
High school and above 1.29 0.48–3.49 0.60
Occupation
Housewife 1.00
Working 3.46 1.33–8.95 0.01
Having a child
No 1.00
Yes 1.85 0.68–5.01 0.22
doi:10.1371/journal.pone.0014177.t003
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vaccination. By January 1, 2010, the vaccination rate among
pregnant women in the United States was 38% [22]. In another
study performed in France that was smilar to the study performed
in the United States the acceptability of 2009 H1N1 vaccine was
37.9% among pregnant women [23].
There are many factors affecting the decisions of pregnant
women in Turkey to receive the 2009 H1N1 vaccination. In our
study, 37.9% of the women stated that they decided on their own
whether or not to vaccinate, 10.5% said that the decision was
made by their spouses, and 51.5% stated that they made the
decision with their spouses. In addition, 68.5% of pregnant women
stated that they were comfortable with their decisions concerning
the vaccine, 7.3% said that they were not comfortable, and 24.2%
stated that they were hesitant. The decisions of having vaccination
were affected by television, health personnel, and suggestions from
relatives. The decisions of not vaccinating were affected by
television, explanations from the Ministry of Health, and
explanations from politicians. Intensive discussions about the
vaccine have taken place in Turkey, and an overall level of anxiety
has developed throughout society about this subject. In the
beginning, the Ministry of Health persistently suggested that
everyone should be vaccinated and also stated that the Prime
Minister and President would be vaccinated. However, the Prime
Minister strongly implied that the Minister of Health should not
speak for him in front of the media. Moreover, the Prime Minister
stated that he and his family would definitely not be vaccinated
[24,25,26]. This situation increased the Turkish society’s hesita-
tions about the vaccine. Almost daily, television programs
discussed 2009 H1N1 and its vaccine, and featured scientists
and politicians defending and contradicting its effectiveness and
dangers [27,28]. These types of discussions and debates could have
fortified society’s hesitation over the vaccination. Moreover, they
could cause vaccination rates to remain low. In our study,
participants expressed that their decisions whether or not to get the
vaccine were mostly affected by television. Our results show that
the media plays the biggest role in informing the public about a
pandemic. In a study performed by Jones et al., participants cited
the internet as the most common source of information concerning
2009 H1N1. Furthermore, the study found that radio, television,
health personnel, and friends were the most common information
sources after the internet [27].
In a study made by Lau et al., one-fourth of the study group felt
that the vaccine was unsafe, one-third believed it to be effective
against influenza, and two-thirds stated that the vaccine had been
approved through clinical experiments [18]. As seen in Table S1,
two-thirds of the pregnant women in the research group stated
that the 2009 H1N1 vaccine had not been approved and would
only be given (as a trial) to the public in Turkey. Three-fourths of
the pregnant women said that there are some other countries
manipulating the receipt of the vaccine, believed that the vaccine
was harmful in the long term, and stated that vaccine companies
were responsible for creating 2009 H1N1. Our results show how
fear is developed in society, and how media broadcasts about
scientific subjects are primarily accredited for conspiracy theories.
Nearly three-fourths of the pregnant women in our study stated
that the vaccine could cause miscarriage, deformation in the child,
and infertility. In a 2006 study by Yudin et al. on pregnant
women, 80% of the participants stated that they believed the
influenza vaccine could lead to defects in their children [28].
These results were similar to what we found in our study.
Possible side effects of the 2009 H1N1 vaccine are: ruddiness,
sensitivity or swelling at the site of vaccination, headache, muscle
and joint aches, fever, nausea, perspiration, chilling, and tremors.
Rare adverse effects include: serious allergic reaction, anaphylaxis,
neuritis, nephritis, vasculitis, thrombocytopenia, convulsion, en-
cephalomyelitis, and Guillain-Barre Syndrome [15,29,30,31].
With respect to such side effects, one-third of the pregnant women
in our study thought that the vaccine could cause ruddiness,
swelling, hardness, cyanosis and pain in the region of vaccination,
lassitude and fatigue. One-fourth of the participants stated that the
vaccine could cause headache, apoplexy and neuropathies,
perspiration and tremors, joint and muscle aches, extensive skin
reaction, and reduction in tension. Other side effects that our
participants less commonly attributed to the vaccine include:
shock, pain throughout the nervous system, and bleeding from
reduced clotting. Although the media had intensively discussed the
adverse effects of the vaccine, the rate of related knowledge in the
study group remained low. This could be because the media hype
caused public confusion about the truths and falsities related to the
vaccine. In a study by Lau et al., half of the research group stated
that the adverse effects of the 2009 H1N1 vaccine were very few or
none, while 16% claimed the effects to be many or severe, and
29% said that they did not know about possible adverse effects
[18]. In our study, 20% of the pregnant women stated that 2009
H1N1 spreads faster than seasonal flu and that its fatality rate was
lower than that of seasonal flu. In a similar study, 36% of the study
group stated that the fatality speed of pandemic flu was higher
than that of seasonal flu and 42% stated that it spread faster [18].
Due to the panicked atmosphere formed throughout society, our
study group could have thought that the fatality of pandemic flu
was higher than that of seasonal flu.
As is evident in the logistic regression model in Table 3, among
the independent variables, the effect of HVSERP points (p=0.04)
and occupation (p=0.01) was statistically significant on vaccina-
tion decision (p,0.05); but the effect of educational status
(p=0.60) and having a child (p=0.22) were not statistically
significant on vaccination decision (p.0.05). The probability of
receiving the 2009 H1N1 vaccine was 3.46 times higher among
working women than housewives, 1.85 times higher among
women who have a child than those who do not, and 1.29 times
higher among women with a high-school education or higher than
those with only a secondary-school education and below. Every
one point increase in the HVSERP score increased the probability
of receiving the 2009 H1N1 vaccine by 1.34 times. These data
show that knowing the vaccine’s side effects about pregnancy
significantly increased the vaccination rate among pregnant
women. This finding shows that during a pandemic, it is critical
to inform at-risk groups about their special condition.
In conclusion, the H1N1 vaccination rate among pregnant
women in our study was too low (8.9%). Half of the study group
stated that they made their decisions with their spouses whether or
not to be vaccinated, and one-third of the group stated that they
felt comfortable with their decisions about vaccination. Every one
point increase in the HVSERP score increased the probability of
receiving the 2009 H1N1 vaccine by 1.34 times. During a
pandemic, it is important that the media work in coordination
with the Ministry of Health and avoid spreading news that
disconcerts society. Also, informing at-risk groups about their risks
is important during a pandemic. Our study’s limitations are that
we performed it in a short time during a single influenza season
and in a single healthcare center. Another limitation is that 2009
H1N1 vaccines started to be distributed among pregnant women
only after the 2009 H1N1 epidemic obviously had started, so the
low uptake rate might have resulted from the delay in
vaccinations. As Schwarzinger et al. said, having influenza-like
symptoms during that time could be associated with the vaccine’s
reduced acceptability in our study [23]. Further studies that
H1N1 Vaccine, Pregnant Women
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in other hospitals and in other influenza seasons for to our results
be generalized.
Supporting Information
Table S1 Distribution of answer ‘yes’ given by 314 pregnant
women concerning 2009 H1N1 vaccine.
Found at: doi:10.1371/journal.pone.0014177.s001 (0.05 MB
DOC)
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